1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Noninvasive determinants of pulmonary hypertension in interstitial lung disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pulmonary hypertension (PH) in interstitial lung disease (ILD) is associated with increased mortality and impaired exertional capacity. Right heart catheterization is the diagnostic standard for PH but is invasive and not readily available. Noninvasive physiologic evaluation may predict PH in ILD. Forty‐four patients with PH and ILD (PH‐ILD) were compared with 22 with ILD alone (non‐PH ILD). Six‐min walk distance (6MWD, 223 ± 131 vs. 331 ± 125 m, p = 0.02) and diffusing capacity for carbon monoxide (DLCO, 33 ± 14% vs. 55 ± 21%, p < 0.001) were lower in patients with PH‐ILD. PH‐ILD patients exhibited a lower gas‐exchange derived pulmonary vascular capacitance (GX CAP, 251 ± 132 vs. 465 ± 282 mL × mmHg, p < 0.0001) and extrapolated maximum oxygen uptake (VO 2max) (56 ± 32% vs. 84 ± 37%, p = 0.003). Multivariate analysis was performed to determine predictors of VO 2 max. GX CAP was the only variable that predicted extrapolated VO 2 max among PH‐ILD and non‐PH ILD patients. Receiver operating characteristic curve analysis assessed the ability of individual noninvasive variables to distinguish between PH‐ILD and non‐PH ILD patients. GX CAP (area under the curve [AUC] 0.85 ± 0.04, p < 0.0001) and delta ETCO 2 (AUC 0.84 ± 0.04, p < 0.0001) were the strongest predictors of PH‐ILD. A CART analysis selected GX CAP, estimated right ventricular systolic pressure (eRVSP) by echocardiogram, and FVC/DLCO ratio as predictive variables for PH‐ILD. With this analysis, the AUC improved to 0.94 (sensitivity of 0.86 and sensitivity of 0.93). Patients with a GX CAP ≤ 416 mL × mmHg had an 82% probability of PH‐ILD. Patients with GX CAP ≤ 416 mL × mmHg and high FVC/DLCO ratio >1.7 had an 80% probability of PH‐ILD. Patients with GX CAP ≤ 416 mL × mmHg and an elevated eRVSP by echocardiogram >43 mmHg had 100% probability of PH‐ILD. The incorporation of GX CAP with either eRVSP or FVC/DLCO ratio distinguishes between PH‐ILD and non‐PH‐ILD with high probability and may therefore assist in determining the need to proceed with a diagnostic right heart catheterization and potential initiation of pulmonary arterial hypertension‐directed therapy in PH‐ILD patients.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found

          2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cardiopulmonary Exercise Testing: What Is its Value?

              Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides a thorough assessment of exercise integrative physiology involving the pulmonary, cardiovascular, muscular, and cellular oxidative systems. Due to the prognostic ability of key variables, CPET applications in cardiology have grown impressively to include all forms of exercise intolerance, with a predominant focus on heart failure with reduced or with preserved ejection fraction. As impaired cardiac output and peripheral oxygen diffusion are the main determinants of the abnormal functional response in cardiac patients, invasive CPET has gained new popularity, especially for diagnosing early heart failure with preserved ejection fraction and exercise-induced pulmonary hypertension. The most impactful advance has recently come from the introduction of CPET combined with echocardiography or CPET imaging, which provides basic information regarding cardiac and valve morphology and function. This review highlights modern CPET use as a single or combined test that allows the pathophysiological bases of exercise limitation to be translated, quite easily, into clinical practice.
                Bookmark

                Author and article information

                Contributors
                phillip.joseph@yale.edu
                Journal
                Pulm Circ
                Pulm Circ
                10.1002/(ISSN)2045-8940
                PUL2
                Pulmonary Circulation
                John Wiley and Sons Inc. (Hoboken )
                2045-8932
                2045-8940
                19 February 2023
                January 2023
                : 13
                : 1 ( doiID: 10.1002/pul2.v13.1 )
                : e12197
                Affiliations
                [ 1 ] Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine Yale New Haven Hospital and Yale School of Medicine New Haven Connecticut USA
                [ 2 ] Department of Biostatistics Yale School of Public Health New Haven Connecticut USA
                [ 3 ] Department of Respiratory Care Yale New Haven Hospital New Haven Connecticut USA
                [ 4 ] Department of Anaesthesiology Yale New Haven Hospital and Yale School of Medicine New Haven Connecticut USA
                Author notes
                [*] [* ] Correspondence Phillip Joseph, Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Yale New Haven Hospital and Yale School of Medicine, New Haven, CT 06511, USA.

                Email: phillip.joseph@ 123456yale.edu

                Author information
                https://orcid.org/0000-0001-9299-8629
                http://orcid.org/0000-0001-5624-1274
                Article
                PUL212197
                10.1002/pul2.12197
                9939578
                36814586
                4a246147-a938-4a82-a58b-06c4c8aebec7
                © 2023 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 04 December 2022
                : 06 August 2022
                : 23 January 2023
                Page count
                Figures: 4, Tables: 6, Pages: 13, Words: 5987
                Funding
                Funded by: NIH
                Award ID: T32NIH‐NRSAHL098069
                Funded by: NIH
                Award ID: T325T32HL007778‐25
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                January 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.5 mode:remove_FC converted:20.02.2023

                Respiratory medicine
                cardiopulmonary exercise testing,interstitial lung disease,pulmonary hypertension

                Comments

                Comment on this article